Longitude Capital Partners III, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Longitude Capital Partners III, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Longitude Capital Partners III, LLC. Longitude Capital Partners III, LLC is 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in Sierra Oncology, Inc. ($SRRA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in 89bio, Inc. ($ETNB) and 10% Owner in Talaris Therapeutics, Inc. ($TALS).
Latest Insider Trading Transactions of Longitude Capital Partners III, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, AXNX, INZY, MTEM, SRRA, TALS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 406,338 | 0 | 0 | |
May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,271,027 | 0 | 0 | |
May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,308,410 | 0 | 0 | |
May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 3,220,775 | 3 M to 3.2 M (+7.87 %) |
May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 2,985,775 | 0 | 2,985,775 | 0 to 3 M |
Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 1,049 | 11,273 | 0 | 1 K to 0 (-100.00 %) |
Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 2,447 | 26,296 | 0 | 2.4 K to 0 (-100.00 %) |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,398,600 | 0 | 0 | |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 15,000,000 | 0 | 0 | |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 2,819,379 | 2.2 M to 2.8 M (+28.48 %) |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 187,154 | 0 | 2,194,379 | 2 M to 2.2 M (+9.32 %) |
Jul 28 2020 | INZY | Inozyme Pharma, In ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 2,007,225 | 0 | 2,007,225 | 0 to 2 M |
Jul 14 2020 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 27.50 | 109,090 | 2,999,975 | 2,600,877 | 2.5 M to 2.6 M (+4.38 %) |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 1,049 | 0 | 1,049 | 0 to 1 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 2,447 | 0 | 2,447 | 0 to 2.4 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 3,495 | 0 | 3,495 | 0 to 3.5 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 3,199,035 | 4.2 M to 3.2 M (-23.81 %) |
Jan 31 2020 | SRRA | Sierra Oncology, I ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 19,500 | 0 | 0 | |
Jan 31 2020 | SRRA | Sierra Oncology, I ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 1,477,320 | 0 | 1,477,320 | 0 to 1.5 M |
Nov 27 2019 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 8.00 | 937,000 | 7,496,000 | 4,198,535 | 3.3 M to 4.2 M (+28.73 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
Nov 02 2018 | AXNX | Axonics Modulation ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
Nov 02 2018 | AXNX | Axonics Modulation ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 15.00 | 533,333 | 7,999,995 | 2,933,333 | 2.4 M to 2.9 M (+22.22 %) |
Nov 02 2018 | AXNX | Axonics Modulation ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 2,400,000 | 0 | 2,400,000 | 0 to 2.4 M |
Sep 25 2018 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 5.50 | 365,000 | 2,007,500 | 3,261,535 | 2.9 M to 3.3 M (+12.60 %) |
Sep 25 2018 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 5.50 | 365,000 | 2,007,500 | 3,261,535 | 2.9 M to 3.3 M (+12.60 %) |
Page: 1